Canaccord Genuity Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $27

Benzinga · 07/01 11:30
Canaccord Genuity analyst Richard Close initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Target of $27.